United States: Interplay Between Inter Partes Reviews (IPRs) And ITC Section 337 Proceedings

Last Updated: June 7 2017
Article by G. Brian Busey and Aaron D. Rauh

Since the passage of the America Invents Act ("AIA") in 2011, Inter Partes Reviews ("IPRs") before the Patent Trial and Appeal Board ("PTAB") have assumed growing importance in patent litigation in federal district courts. Until recently, IPRs have not played a significant role in International Trade Commission ("ITC") Section 337 investigations. While the ITC is unlikely to stay a Section 337 investigation, pending IPRs will likely have an increasing impact at the ITC, especially when an IPR proceeding reaches an advanced stage before or during the pendency of a Section 337 investigation. This article examines the limited interplay to date between IPRs and Section 337 proceedings and discusses potential implications for future investigations.

IPRs under the AIA

Pursuant to the AIA, defendants accused of patent infringement and third parties may challenge the validity of patents before the PTAB. An accused infringer must file an IPR petition within one year of being served with a complaint alleging patent infringement in district court.1 However, the one-year time limit does not apply to Section 337 investigations because they are not "civil actions" for patent infringement.2 As a practical matter, because complaints in Section 337 cases are often accompanied by parallel district court complaints, the one-year time limit on filing IPRs will frequently apply.

The AIA narrowed the bases on which an alleged infringer or third party can challenge patent validity in IPRs as compared to those available in district court or at the ITC. A party through an IPR can challenge validity based on anticipation (35 U.S.C. § 102) and on obviousness (35 U.S.C. § 103) grounds. However, an IPR can be based only on prior art patents or printed publications; IPRs cannot be based on a commercial device or system.3 Therefore, a party accused of infringement cannot use IPRs to challenge patent validity on other bases, such as indefiniteness (35 U.S.C. § 112) or patentability (35 U.S.C. § 101).

The standards of proof in IPR proceedings are also different from validity challenges in federal district court or at the ITC. For example, the standard for institution of an IPR proceeding is a "reasonable likelihood . . . petitioner would prevail."4 This standard has led to a fairly high rate for institution of IPRs.5 Also, with respect to claim construction, the PTAB generally uses the "broadest reasonable interpretation" standard rather than the Phillips standard of how a person of ordinary skill in the art would interpret claims in light of the claim language, the patent specification and the prosecution history, which is used in federal district court and the ITC.6 Importantly, the standard for showing invalidity in an IPR is a "preponderance of the evidence"7 instead of the higher "clear and convincing standard" used in district court.8

The different standards of proof used in IPR proceedings has resulted in validity challenges having a higher success rate in comparison to district court proceedings. For example, according to the PTO's most recent statistics, of the IPRs reaching final written decision, 67 percent have resulted in all claims cancelled, 16 percent resulted in a partial finding of invalidity, and 17 percent resulted in no finding of invalidity.9

Stays in District Court versus the ITC

A significant advantage of IPRs for an accused infringer is that defendants can often obtain a stay of a district court infringement case based upon filing or institution of an IPR. Although the success of motions to stay varies based upon the particular district and judge, district courts as a whole have granted approximately 58-81 percent of stay requests based on IPRs.10 Moreover, even if stays are denied preliminarily they are denied without prejudice and later may be granted.11 District courts are more likely to grant stays after an IPR has been instituted.12

By contrast with the district courts, the ITC to date has not granted a single stay of a Section 337 investigation based on a pending IPR. There are a number of reasons for this difference. Perhaps the most important reason, and one frequently cited by the ITC Judges when stays are denied, is the statutory language of Section 337, which requires the ITC to conclude investigations "at the earliest practicable time."13

Another important fact is the typical timeline of an IPR proceeding compared to that of a Section 337 investigation. The normal timeline for an IPR proceeding is roughly 18 months, with institution often occurring approximately six months after the petition is filed. The PTAB's Final Written Decision is due no later than one year after institution (unless extended by six months),14 meaning that the typical IPR may take 18 months from filing to complete (excluding any Federal Circuit appeal). In contrast, ITC Judges in Section 337 investigations commonly set target dates of 16 months from institution for the ITC to issue a final determination. Indeed, if an ITC Judge sets or extends a target date beyond 16 months, such a decision must be certified for review by the Commission.15 Thus, in most cases, the ITC will complete its investigation within 16 months.16 By comparison, it may take several years for a patent infringement case to reach final judgment in district court.

The ITC uses a multi-factor test in assessing whether to grant a stay, including at least the following factors:

  1. the state of discovery and hearing date;
  2. whether a stay will simplify the issues;
  3. undue prejudice to any party;
  4. the stage of PTO proceedings; and
  5. efficient use of Commission resources.17

In Semiconductor Chips, the Commission reversed the decision of an ITC Judge who granted a stay based on near final ex parte reexaminations. The Commission emphasized its statutory mandate to complete 337 investigations "as soon as practicable."18 The Commission also noted that stays pending PTO proceedings are especially disfavored if the subject patent is relatively near its expiration date to avoid unfair prejudice to patent holders seeking to enforce their rights.19 Regarding factor 5 (efficient use of Commission resources), the Commission found that, while this factor will almost always weigh in favor of granting a stay, this factor is not determinative, and its weight is diminished once an investigation reaches a "relatively advanced stage."20

One of the more recent decisions denying a stay based on IPRs illustrates the reasons why ITC Judges are hesitant to grant such stays.21 As in other denials, the ITC Judge emphasized the statutory mandate to complete Section 337 investigations "at the earliest practicable time."22 The Judge also noted that the PTAB's decision would not necessarily simplify the investigation because the invalidity issues, including indefiniteness under Section 112, were broader than those in the pending IPR.23 The ITC Judge also reasoned that, although the IPR in this case was filed 15 days before the ITC complaint, it would not become final (excluding any Federal Circuit appeal) until approximately the Judge's Initial Determination and thus the any "insights that emerge" from the IPR decision could be incorporated into the investigation.24 Finally, the Judge concluded that granting the requested stay may prejudice the patent holder by allowing continued imports of potentially infringing products for a period of years.25

Another earlier decision also highlights the difficulties that an IPR petitioner may have in obtaining a stay at the ITC.26 In MEMs Devices, Inv. No. 337-TA-876, IPR petitions were filed approximately one week before and one week after the investigation was instituted, and three ex parte reexaminations were underway but not yet in advanced stages.27 Moreover, a prior district court action involving the same patents asserted in the ITC was stayed based on the PTO proceedings.28 The ITC Judge concluded that factors 1 (the state of discovery and hearing date) and 2 (whether a stay will simplify the issues) supported a stay because the respondent "filed promptly for a stay—approximately two weeks after institution" and that there was a danger of duplication of efforts if the asserted patents were altered or invalidated.29 But the Judge concluded that it was "unlikely that a resolution for all five asserted patents will be reached prior to the end of the 16 month period allotted for this Investigation," given the average length of the PTO proceedings, and therefore denied the stay.30 In denying the stay, however, the ITC Judge did request periodic updates on the status of PTO proceedings.31

Most recently, in Hybrid Vehicles, Inv. No. 337-TA-1042, the ITC was presented with a complaint involving five asserted patents, with the majority (but not all) of the asserted claims subject to several pending IPRs.32 A parallel district court action filed in 2014, alleging infringement of the same patents, was stayed based on the pending IPRs.33 Many of the asserted claims of these patents had been rejected in final determinations by PTAB.34 Several of the PTAB decisions were subject to appeals that had been argued before the Federal Circuit.35 Respondent Ford Motor Co. requested that the ITC suspend or delay institution based on the near final IPRs; however, the ITC proceeded to institute the investigation.36 Therefore, absent circumstances where appeals of IPRs concerning all of the asserted claims are nearly completed, the ITC seems unlikely to stay or withhold institution of an investigation.

Potential for IPRs to Affect ITC Remedy Decisions

In a recent decision, the ITC has acknowledged that it may be appropriate for IPRs to be given some weight in remedy determinations.37 In Three Dimensional Cinema Systems, Inv. No. 337-TA-939, the ITC gave weight to a final PTAB decision, issued after the Judge's Initial Determination, rejecting two claims (claims 1 and 6) of the one of the asserted patents that the Commission had found infringed.38 The Commission held that, "[i]n light of the advanced posture of the IPR proceeding . . . the Commission has determined to exercise its discretion and suspend enforcement of the remedial orders as to the asserted claims of the '934 patent" pending Federal Circuit appeal of the PTAB decision.39 Interestingly, the ITC suspended remedy enforcement not only as to the two claims rejected in the PTAB decision, but also as to a third claim that was not subject to the PTAB decision.40 The ITC took that action because the finding of violation as to the subject patent was premised in part on satisfaction of the technical prong of the domestic industry requirement based solely on claim 1, which the PTAB rejected.41

The determination on remedy in Three-Dimensional Cinema Systems reflects the Commission's recognition that, in the right circumstances – i.e. an "advanced posture" IPR – it may be appropriate for the ITC to exercise discretion to withhold or suspend a remedy based on rejected claims.

Implications for the Future

Barring a final Federal Circuit appeal of an IPR that completely invalidates all asserted claims occurring during the pendency of a Section 337 investigation, a stay of a Section 337 investigation remains unlikely. However, recent decisions indicate that IPR proceedings are having an increasing impact at the ITC. Given the high percentage of district court cases stayed in view of IPRs, patent owners are increasingly turning to the ITC as an alternative forum to assert their patents in parallel to IPR proceedings. Thus, there is an increasing likelihood that the ITC will see more complaints where IPR proceedings are already underway and where PTAB decisions may have issued. In view of this development, the Commission and Judges have recognized the interplay between pending investigations and IPRs and have begun to accord some evidentiary weight to the PTAB's decisions.

In Certain Composite Aerogel Insulation Materials, Inv. No. 337-TA-1003, the presiding ITC Judge recently reopened the evidentiary record after the hearing to receive two PTAB decisions denying institution of the respondents' IPRs.42 While noting that the PTAB decisions were not final and based on a different evidentiary standard and record, the Judge recognized the relevance of the PTAB's decisions, which "discuss at length multiple pieces of prior art that Respondents have relied upon in this Investigation, including Respondents' primary reference."43

In another recent order, the presiding ITC Judge struck an inequitable conduct defense based on a PTAB final decision finding the subject evidence was not material.44 The Judge held that, even though "it may be atypical at this stage in a proceeding [approximately four months into the investigation] to make a finding of fact," based on the PTAB's finding, the respondent would be unable to prove the "but for materiality" prong of inequitable conduct.45

Thus, it appears likely that the Commission and the ITC Judges will be required to increasingly consider parallel IPR proceedings in ongoing Section 337 investigations, particularly where IPRs are at "advanced" stages.

Appreciation to the Federal Circuit Bar Association April 2017 Newsletter, a publication of the Federal Circuit Bar Association, for this limited use.


1 See 35 U.S.C. § 315(b).

2 The Brinkmann Corp. v. A&J Manufacturing, LLC, IPR 2015-00056, Paper 10 at 7-8 (PTAB Mar. 23, 2015).

3See 35 U.S.C. § 311(b).

435 U.S.C. §314(a).

5 See U.S. Patent and Trademark Office: Patent Trial and Appeal Board Statistics at 7-8 (Feb. 28, 2017), https://www.uspto.gov/sites/default/files/documents/aia_statistics_february2017.pdf.

6 See Phillips v. AWH Corp., 415 F.3d 1303 (Fed. Cir. 2005) (en banc); see, e.g., Certain Dental Implants, Inv. No. 337-TA-934, Comm'n Op. at 10 (May 11, 2016) (applying the Phillips standard).

7 See 35 U.S.C. § 316(e).

8 See 35 U.S.C. § 282(a) ("A patent shall be presumed valid."); Microsoft Corp. v. i4i Limited Partnership, 564 U.S 91 (2011) (affirming the "clear and convincing" evidentiary standard for proving patent invalidity).

9 See U.S. Patent and Trademark Office: Patent Trial and Appeal Board Statistics at 10 (Feb. 28, 2017), https://www.uspto.gov/sites/default/files/documents/aia_statistics_february2017.pdf.

10 See Jonathan Stroud, Linda Thayer and Jeffrey C. Totten, Stay a While: The Evolving Law of District Court Stays in Light of Inter Partes Review, Post-Grant Review, and Covered Business Method Post-Grant Review, 11 Buffalo Intellectual Property L.J. 226, at 237-38 (2015).

11 See id.

12 See id. at 241.

13 19 U.S.C. 1337(b)(1).

14 See 35 U.S.C. § 316(a)(11).

15 See 19 C.F.R. § 210.51(a)(1).

16 According to recent ITC statistics, the average length of investigations completed on the merits as to violation was 15.6 months and 15.8 months in fiscal years 2015 and 2016, respectively. See U.S. International Trade Commission: Section 337 Statistics: Average Length of Investigations (Apr. 7, 2017), https://www.usitc.gov/intellectual_property/337_statistics_average_length_investigations.htm.

17 See Certain Semiconductor Chips with Minimized Chip Package Size and Products Containing Same, Inv.
No. 337-TA-605, Comm'n Op. at 3-4 (May 27, 2008). A sixth factor, whether alternative relief is available in federal court, is also sometimes considered. See, e.g., Certain Laser Driven Light Sources, Subsystems Containing Laser-Light Sources, and Products Containing Same, Inv. No. 337-TA-983, Order No. 8 at 5 (Mar. 3, 2016) (citing Certain Pers. Comput./Consumer Elec. Convergent Devices, Components Thereof, and Prods. Containing Same, Inv. No. 337-TA-558, Order No. 6 (Feb. 7, 2006).

18 Certain Semiconductor Chips, Inv. No. 337-TA-605, Comm'n Op. at 6, 9.

19 See id. at 9.

20 Id. at 13.

21 See Certain Laser Driven Light Sources, Inv. No. 337-TA-983, Order No. 8.

22 Id. at 4.

23 See id. at 6-7.

24 See id. at 8.

25 See id.

26 Certain Microelectromechanical Systems ("MEMs Devices") and Products Containing Same, Inv. No. 337-TA-876, Order No. 6 (May 21, 2013).

27 See id. at 5.

28 See id. at 7.

29 Id. at 3-4.

30 Id. at 6, 8.

31 See id. at 8.

32 See Certain Hybrid Vehicles and Components Thereof, Inv. No. 337-TA-1042, Complaint at 61-62 (Feb. 2, 2017).

33 See id. at 61.

34 See id. at 62.

35 See id.

36 The Federal Circuit issued decisions affirming the PTAB's decisions invalidating certain claims in two of the appeals shortly after institution. See Paice LLC v. Ford Motor Co., No. 2016-1412, 2017 WL 900062 (Fed. Cir. Mar. 7, 2017); Paice LLC v. Ford Motor Co., No. 2016-1412, 2017 WL 900062 (Fed. Cir. Mar. 7, 2017). Furthermore, on April 21, the Federal Circuit issued decisions affirming the PTAB's decisions invalidating certain claims in two more of the appeals. See Paice LLC v. Ford Motor Co., No. 2016-1411 (Fed. Cir. Apr. 21, 2017); Paice LLC v. Ford Motor Co., No. 2016-1746 (Fed. Cir. Apr. 21, 2017).

37 Certain Three Dimensional Cinema Systems and Components Thereof, Inv. No. 337-TA-939, Comm'n Op. (Aug. 23, 2016).

38 See id. at 60 (Aug. 23, 2016).

39 Id.

40 See id.

41 See id. at 60 n.31.

42 See Certain Composite Aerogel Insulation Materials and Methods for Manufacturing the Same, Inv.
No. 337-TA-1003, Order No. 37 (Apr. 6, 2017).

43 Id. at 2-3.

44 See Certain UV Curable Coatings for Optical Fibers, Coated Optical Fibers, and Products Containing Same, Inv. No. 337-TA-1031, Order No. 9 (Mar. 27, 2017).

45 Id. at 10-11.

Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Morrison & Foerster LLP. All rights reserved

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

G. Brian Busey
Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions